← Back to home

LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY

Clinical trials for LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY trials appear

Sign up with your email to follow new studies for LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

New hope for kids with tough blood cancers: trial tests targeted drug combo

Disease control Not yet recruiting

This trial is testing a new combination of three drugs—capivasertib, venetoclax, and dexamethasone—for children and young adults whose leukemia or lymphoma has come back or hasn't responded to standard treatments. The main goals are to find the safest dose and see if this combina…

Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY

Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY

Get alerted when new LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY trials appear

New hope for kids with tough blood cancers: trial tests targeted drug combo